• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria.尼日利亚西南部地区报告的肺结核(PTB)病例中的利福平耐药情况。
Heliyon. 2019 Jul 16;5(7):e02096. doi: 10.1016/j.heliyon.2019.e02096. eCollection 2019 Jul.
2
Prevalence of Rifampicin-Resistant Tuberculosis among Patients Previously Treated for Pulmonary Tuberculosis in North-Western, Nigeria.尼日利亚西北部曾接受过肺结核治疗的患者中耐利福平结核病的患病率
Niger Med J. 2017 Nov-Dec;58(6):161-166. doi: 10.4103/nmj.NMJ_41_17.
3
Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.Xpert MTB/RIF对从复治肺结核患者中筛查出的耐多药或利福平耐药结核病治疗效果的前瞻性队列研究。
Ann Palliat Med. 2020 Mar;9(2):239-246. doi: 10.21037/apm.2020.02.17. Epub 2020 Mar 17.
4
Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.Xpert MTB/RIF 检测对中国上海肺结核病例和利福平耐药性检测的影响。
BMC Infect Dis. 2020 Feb 18;20(1):153. doi: 10.1186/s12879-020-4871-9.
5
Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda.乌干达药物敏感和耐药肺结核患者的胸部X光检查结果
J Clin Tuberc Other Mycobact Dis. 2022 Mar 25;27:100312. doi: 10.1016/j.jctube.2022.100312. eCollection 2022 May.
6
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核和利福平耐药性的Xpert® MTB/RIF检测
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
7
HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center.2015年至2019年中国HIV阴性的利福平耐药/耐多药肺外结核病:一项来自国家结核病临床研究中心的临床回顾性调查研究
Infect Drug Resist. 2022 Mar 19;15:1155-1165. doi: 10.2147/IDR.S342744. eCollection 2022.
8
Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria.尼日利亚拉各斯一家二级转诊医院疑似结核病患者中耐利福平结核病的患病率及相关因素
Afr Health Sci. 2018 Sep;18(3):472-478. doi: 10.4314/ahs.v18i3.2.
9
Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴涂片阴性疑似肺结核患者中结核病、耐多药结核病及相关危险因素的流行情况。
BMC Infect Dis. 2019 Jul 19;19(1):641. doi: 10.1186/s12879-019-4241-7.
10
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.加强结核病病例检测:为儿童疑似结核病和耐多药结核病病例提供即时Xpert MTB/RIF检测以早期快速诊断药物敏感型和耐药型结核病的经验。
PLoS One. 2014 Aug 20;9(8):e105346. doi: 10.1371/journal.pone.0105346. eCollection 2014.

引用本文的文献

1
Risk factors for rifampicin resistance tuberculosis among patients attending Directly Observed Treatments Centres in Southwestern Nigeria.尼日利亚西南部直接观察治疗中心患者中耐利福平结核病的危险因素。
Pan Afr Med J. 2024 Nov 22;49:87. doi: 10.11604/pamj.2024.49.87.43958. eCollection 2024.
2
BACTERIAL AND FUNGAL INFECTIONS IN PULMONARY TUBERCULOSIS PATIENTS AND THE DRUG SENSITIVITY TEST PATTERNS.肺结核患者的细菌和真菌感染及药敏试验模式
Afr J Infect Dis. 2024 Oct 25;19(1):21-28. doi: 10.21010/Ajidv19i1.3. eCollection 2025.
3
and rifampicin-resistant tuberculosis among tuberculosis presumptive patients in selected zones of Tigray, Northern Ethiopia, 2016-2019.2016 - 2019年埃塞俄比亚北部提格雷选定地区疑似结核病患者中的耐利福平结核病情况
Heliyon. 2024 Jun 28;10(13):e33863. doi: 10.1016/j.heliyon.2024.e33863. eCollection 2024 Jul 15.
4
Detection of and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021.2014年至2021年期间,在埃塞俄比亚亚的斯亚贝巴疑似结核病患者中通过Xpert® MTB/RIF检测法检测结核分枝杆菌及利福平耐药性。
IJID Reg. 2022 Sep 8;5:97-103. doi: 10.1016/j.ijregi.2022.09.001. eCollection 2022 Dec.
5
Status of drug resistant tuberculosis among patients attending a tuberculosis unit of West Bengal: A record based cross-sectional study.西孟加拉邦一家结核病治疗单位患者中耐多药结核病的状况:一项基于记录的横断面研究。
J Family Med Prim Care. 2022 Jan;11(1):84-89. doi: 10.4103/jfmpc.jfmpc_576_21. Epub 2022 Jan 31.
6
Prevalence of infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital, Southern Ethiopia.埃塞俄比亚南部阿达雷综合医院结核病门诊疑似结核病患者的感染率及利福平耐药率
SAGE Open Med. 2021 Sep 15;9:20503121211045541. doi: 10.1177/20503121211045541. eCollection 2021.
7
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015-2019.2015 - 2019年埃塞俄比亚阿姆哈拉东部地区肺结核疑似患者中结核分枝杆菌(耐利福平结核分枝杆菌)的患病率及相关风险因素
Infect Dis Ther. 2021 Sep;10(3):1299-1308. doi: 10.1007/s40121-020-00368-5. Epub 2021 May 5.
8
INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA.尼日利亚凯比州门诊患者中利福平耐药疑似病例的发生率
Afr J Infect Dis. 2020 Dec 14;15(1):47-52. doi: 10.21010/ajid.v15i1.6. eCollection 2021.
9
Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.在埃塞俄比亚提格雷北部,使用 Xpert-MTB/RIF 检测成人疑似肺结核患者中 MTB 和利福平耐药 MTB 的频率:一项横断面研究。
PLoS One. 2020 Nov 4;15(11):e0240361. doi: 10.1371/journal.pone.0240361. eCollection 2020.
10
High Prevalence of Rifampicin Resistance Associated with Rural Residence and Very Low Bacillary Load among TB/HIV-Coinfected Patients at the National Tuberculosis Treatment Center in Uganda.乌干达国家结核病治疗中心结核/艾滋病毒合并感染患者中农村居住与极低细菌载量与利福平耐药高度相关。
Biomed Res Int. 2020 Jul 25;2020:2508283. doi: 10.1155/2020/2508283. eCollection 2020.

本文引用的文献

1
Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria.尼日利亚耶纳戈阿肺结核患者中通过自动化GeneXpert利福平检测法检测的利福平耐药率
Pan Afr Med J. 2018 Apr 6;29:204. doi: 10.11604/pamj.2018.29.204.14579. eCollection 2018.
2
Molecular Epidemiology of Rifampicin Resistance in Using the GeneXpert MTB/RIF Assay from a Rural Setting in India.在印度农村地区使用GeneXpert MTB/RIF检测法对利福平耐药性进行分子流行病学研究。
J Pathog. 2017;2017:6738095. doi: 10.1155/2017/6738095. Epub 2017 Oct 26.
3
Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis.尼日利亚耐多药结核病的患病率:一项系统评价与荟萃分析。
PLoS One. 2017 Jul 13;12(7):e0180996. doi: 10.1371/journal.pone.0180996. eCollection 2017.
4
Rifampicin-resistant among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia.埃塞俄比亚西北部贡德尔大学医院疑似结核病病例中的利福平耐药情况。
Infect Drug Resist. 2017 Jun 14;10:185-192. doi: 10.2147/IDR.S135935. eCollection 2017.
5
Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan.巴基斯坦耐药结核分枝杆菌的耐药模式及耐药性发展的相关危险因素
PLoS One. 2016 Jan 25;11(1):e0147529. doi: 10.1371/journal.pone.0147529. eCollection 2016.
6
Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study.巴基斯坦城市地区耐多药结核病的危险因素:一项多中心病例对照研究。
Int J Mycobacteriol. 2012 Sep;1(3):137-42. doi: 10.1016/j.ijmyco.2012.07.007. Epub 2012 Sep 2.
7
Biological differences between the sexes and susceptibility to tuberculosis.性别差异与结核病易感性。
J Infect Dis. 2014 Jul 15;209 Suppl 3:S100-6. doi: 10.1093/infdis/jiu147.
8
Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China.中国东北地区某当地医院耐药结核病的患病率及特征
Int J Infect Dis. 2014 May;22:83-6. doi: 10.1016/j.ijid.2013.12.015. Epub 2014 Feb 17.
9
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.南非夸祖鲁-纳塔尔省结核分枝杆菌利福平单耐药:高结核和艾滋病毒流行地区的一个显著现象。
PLoS One. 2013 Nov 6;8(11):e77712. doi: 10.1371/journal.pone.0077712. eCollection 2013.
10
High prevelance of rifampin-monoresistant tuberculosis: a retrospective analysis among Iranian pulmonary tuberculosis patients.利福平单耐药结核的高流行率:伊朗肺结核患者的回顾性分析。
Am J Trop Med Hyg. 2014 Jan;90(1):99-105. doi: 10.4269/ajtmh.13-0057. Epub 2013 Nov 4.

尼日利亚西南部地区报告的肺结核(PTB)病例中的利福平耐药情况。

Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria.

作者信息

Ukwamedua Henry, Omote Victor, Etaghene Johnson, Oseji Matthew Ejike, Agwai Imaria Celia, Agbroko Harrison

机构信息

Department of Laboratory Services, Central Hospital Warri, Nigeria.

Department of Public Health, Ministry of Health, Asaba, Delta State, Nigeria.

出版信息

Heliyon. 2019 Jul 16;5(7):e02096. doi: 10.1016/j.heliyon.2019.e02096. eCollection 2019 Jul.

DOI:10.1016/j.heliyon.2019.e02096
PMID:31360790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6639537/
Abstract

BACKGROUND

Rifampicin resistant pulmonary tuberculosis (RR-PTB) remains a global health burden especially in low income countries and among HIV positive individuals.

OBJECTIVE

This study seeks to measure the prevalence of RR-PTB among confirmed PTB cases in Delta State South-Southern, Nigeria and to determine the correlation between various factors affecting the prevalence of RRTB among notified pulmonary TB cases.

MATERIAL AND METHODS

The study is cross-sectional and retrospective in design and was carried out in Delta State, South-Southern Nigeria among participants with notified pulmonary TB cases. Gene Xpert registers for the selected facilities (Central Hospital Warri, Central Hospital Sapele and Federal Medical Center Asaba) for the year 2017 were retrieved, data extracted and analyzed.

RESULT

Prevalence of RR-PTB was 7.3% (47/643). Majority (11.3% and 11.4%) of RR-PTB cases were among ages 0-20 and 61-80 years respectively. The male group and HIV negative participants gave rates of 9.1% and 7.8% respectively. Rates reported for location of residence revealed that Delta Central had a rate that doubled Delta South and tripled Delta North.

CONCLUSION

Although our study figures are lower when compared to other reports for the study region, age grades 0-20 and 61-80 years, the male gender and residence in Delta Central were highlighted as independent variables that influence the distribution of RR-PTB. While a call for the sustenance and if possible augmentation of control and eradication efforts is of high essence, further studies aimed at identifying and understanding co-variables to the ones highlighted are recommended.

摘要

背景

耐利福平肺结核(RR-PTB)仍是一项全球卫生负担,在低收入国家以及艾滋病毒阳性个体中尤为如此。

目的

本研究旨在测定尼日利亚南南地缘政治区三角州确诊肺结核病例中RR-PTB的患病率,并确定影响已通报肺结核病例中RR-PTB患病率的各种因素之间的相关性。

材料与方法

本研究采用横断面回顾性设计,在尼日利亚南南地缘政治区三角州对已通报肺结核病例的参与者开展。检索了2017年选定机构(瓦里中央医院、萨佩莱中央医院和阿萨巴联邦医疗中心)的Gene Xpert登记信息,提取并分析了数据。

结果

RR-PTB的患病率为7.3%(47/643)。RR-PTB病例大多分别在0至20岁(11.3%)和61至80岁(11.4%)年龄段。男性组和艾滋病毒阴性参与者的患病率分别为9.1%和7.8%。所报告的居住地点患病率显示,三角州中部的患病率是三角州南部的两倍,是三角州北部的三倍。

结论

尽管与该研究区域的其他报告相比,我们的研究数据较低,但0至20岁和61至80岁年龄组、男性以及居住在三角州中部被突出显示为影响RR-PTB分布的独立变量。虽然维持并在可能的情况下加强控制和根除努力至关重要,但建议开展进一步研究,以确定并了解与所突出显示变量相关的协变量。